Fishawack Communications is a global leader in healthcare communications and consulting, supporting pharmaceutical, biotechnology, and medical device companies worldwide. The company specialises in medical strategy, scientific communications, and creative services, delivering innovative solutions that help clients navigate complex healthcare landscapes and improve patient outcomes.
Fishawack
A global healthcare communications specialist
Website
YFM investment
£4.5m - 1.9x return
Investment date(s)
2008, 2009, 2010 - 2013
Deal type
Buyout
Location
UK, USA and Switzerland
"We have worked closely with YFM since the MBO, strengthening and developing a new strategy to accelerate growth. YFM is a strong partner at this time of transformation and funded the first three acquisitions."
Key Information
The Business
Why We Invested
Fishawack Communications is a global leader in healthcare communications and consulting, supporting pharmaceutical, biotechnology, and medical device companies worldwide. The company specialises in medical strategy, scientific communications, and creative services, delivering innovative solutions that help clients navigate complex healthcare landscapes and improve patient outcomes.
Growth Story
Under YFM’s ownership, Fishawack achieved significant milestones:
- Strategic Acquisitions: Follow-on funding facilitated three key acquisitions:
- Alpha-Plus Medical Communications – Strengthened expertise in scientific communications.
- Phocus Consulting – Enhanced consultancy services for pharmaceutical clients.
- Healthcare21 – Expanded the company’s market presence and client base in medical communications.
- Grew its international footprint to serve global clients across multiple regions.
- Increased its team of healthcare communication experts, enabling the company to deliver specialised and innovative services.
- Positioned itself as a trusted partner for some of the world’s largest pharmaceutical and biotech firms.
Outcome
In 2013, YFM Equity Partners successfully exited its investment in Fishawack Communications through a secondary sale to Growth Capital Partners. The transaction provided a strong return for YFM investors and marked the beginning of a new phase for Fishawack. Under new ownership, the company continued to grow, leveraging its enhanced capabilities and expanded reach to further establish itself as a leader in healthcare communications.